Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03045874 · ClinicalTrials.gov registry record
Community Partnership for Healthy Sleep
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 83
- Enrollment target
NCT03045874: Completed study, sponsored by Yale University.
NCT03045874 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03045874 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct community-engaged research (CEnR) with families and pediatric providers caring for the children in those families to address the following specific aims: 1. Examine parents' knowledge and perceptions about their 6-36 month old children's sleep and objective characteristics of sleep, including (1a) self-reported and actigraph-recorded characteristics of sleep, sleep habits, and difficulty; (1b) the contributions of sleep habits and individual, family, community, cultural/social, and health-related factors to sleep characteristics and sleep difficulty; (1c) consequences of sleep difficulty; (1d) successful and unsuccessful strategies used to promote children's sleep and sleep habits; (1e) preferences regarding sleep promotion interventions for their children; and perceptions of the optimal timing to begin sleep promotion intervention 2. Examine pediatric primary care providers' perceptions about (2a) the importance of sleep and sleep habits for 6-36 month old children; (2b) factors that contribute to sleep habits and sleep difficulty; (2c) successful and unsuccessful approaches to promote healthy sleep habits, adequate duration and good quality sleep and assessment and management of sleep difficulty in young children within the context of their families; and (2c) barriers, facilitators, and preferences regarding sleep-promoting interventions for families with young children; 3. Collaborate with families and providers to use the information obtained in Aims 1 and 2 to develop and refine a feasible, relevant, and acceptable sleep promotion program, including procedures, protocols, patient materials, intervention fidelity plans, and delivery methods.
Primary Outcome
A member of the research team experienced in qualitative interviewing will conduct the parent interviews in a private space at the PCC, Yale School of Nursing (YSN), or other convenient location at a time separate from a health care visit. Investigators will use a semi-structured guide organized by the constructs of interest (e.g. sleep characteristics, importance of sleep, sleep habits, contributing factors). Open-ended prompts will be used to explore ideas. Interview data will be digitally tr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2017-02-23 |
| Est. Completion | 2019-05-30 |
What the finished NCT03045874 record still lists
NCT03045874 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03045874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03045874 about?
NCT03045874 is a clinical study titled "Community Partnership for Healthy Sleep". The purpose of this study is to conduct community-engaged research (CEnR) with families and pediatric providers caring for the children in those families to address the following specific aims: 1. Examine parents' knowledge and perceptions about their 6-36 month old children's sleep and objective c...
What is the current status of trial NCT03045874?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2017-02-23. Estimated completion is 2019-05-30.
Who is sponsoring clinical trial NCT03045874?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI